SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drug’s arm secures tender worth $9.13 million

26 Feb 2024 Evaluate

Kilitch Drug’s subsidiary -- Kilitch Estro Biotech PLC has secured a significant tender issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia. This tender win marks a notable achievement for the company not only because of this tender but also it will definitely repeat as the Ethiopian Pharmaceutical Supply Service has planned to purchase injectable from local manufacturer.

The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to $9.13 million. The contract is executable within a timeline of six months from the receipt of the order, highlighting the efficiency and capability of the company’s subsidiary in fulfilling such large-scale contracts. This accomplishment further solidifies the company’s position in the pharmaceutical industry, showcasing its ability to secure substantial contracts and expand its presence in international markets. 

Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms. 


Kilitch Drugs(India) Share Price

135.10 4.55 (3.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×